Influenza Update N° 523

Overview

Published 23 April 2025 | For reporting Week 15, ending 13 April 2025

Influenza

  • In the Northern hemisphere, activity continued to decline or remained at low level in most countries. Minor increases in activity were reported in a few countries in Tropical South America, Western Africa, Eastern Europe and Eastern Asia. Influenza positivity remained elevated (>10%) in the Americas (predominantly A(H1N1)pdm09), Western Africa (predominantly A(H1N1)pdm09), Northern Africa, Eastern Africa (predominantly A(H1N1)pdm09 and A(H3N2)), in Europe (predominantly A(H3N2) and B viruses), and Western (predominantly A(H3N2) and B), Southern (predominantly A(H3N2)), Southeast (predominantly A(H1N1)pdm09 and B) and Eastern Asia (predominantly A(H1N1)pdm09).
  • In the Southern hemisphere, influenza positivity was generally low (<10%) except in a few countries in Southern (predominantly A(H3N2)), Eastern Africa and Oceania (predominantly A(H1N1)pdm09). Activity remained at low level or decreased in all countries except for a small increase in a few countries in Temperate South America.
 

SARS-CoV-2

  • Globally, activity decreased or remained at low level in most countries except for a few countries in Central America and the Caribbean, Southwest Europe and Western Asia where positivity was also elevated (>10%). Positivity was also elevated in single countries in Temperate South America and Eastern Asia.
WHO encourages countries, especially those that have received the multiplex influenza and SARS-CoV-2 reagent kits from GISRS, to conduct integrated surveillance of influenza and SARS-CoV-2 and report epidemiological and laboratory information in a timely manner to established regional and global platforms. The guidance can be found here https://covid.comesa.int/publications/i/item/WHO-2019-nCoV-integrated_sentinel_surveillance-2022.1.
 

Starting with report #501, the Global Respiratory Virus Activity Weekly Update included data from sentinel surveillance and other types of systematically conducted virologic surveillance. Countries, areas, and territories use a variety of approaches to monitor respiratory virus activity and data in this report may vary from surveillance reports posted elsewhere. Analyses stratified by source of surveillance is available through Respimart.

 

 

WHO Team
Global Influenza Programme (GIP)